InfuSystem Holdings, Inc·4

May 14, 6:32 PM ET

SVIOKLA JOHN J 4

4 · InfuSystem Holdings, Inc · Filed May 14, 2026

Research Summary

AI-generated summary of this filing

Updated

InfuSystem (INFU) Director John J. Sviokla Receives Option Award

What Happened
John J. Sviokla, a director of InfuSystem Holdings, Inc. (INFU), received a derivative award on May 12, 2026 representing the right to purchase 24,890 shares. The Form 4 reports the award as acquired at $0.00 (derivative instrument) — this is an option-style grant, not an immediate purchase of stock.

Key Details

  • Transaction date: May 12, 2026; Form 4 filed: May 14, 2026 (appears timely).
  • Transaction type/code: Award/Grant (A); 24,890 option shares reported as acquired at $0.00.
  • Vesting: The option vests on May 12, 2027 (see footnote).
  • Shares owned after transaction: Not specified in the provided filing.
  • Notes: This is a derivative (option) award. No exercise or sale occurred in this filing; any future exercise/sale would be reported separately.

Context
Option grants are common compensation for directors and vesting schedules mean the right to buy shares becomes exercisable later. This award does not indicate an immediate purchase or sale of shares — it's an entitlement to buy in the future under whatever exercise terms apply (exercise price and other terms not disclosed in the provided excerpt).

Insider Transaction Report

Form 4
Period: 2026-05-12
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-12+24,89024,890 total
    Exercise: $8.37From: 2027-05-12Exp: 2036-05-12Common Stock (24,890 underlying)
Holdings
  • Common Stock

    10,000
Footnotes (1)
  • [F1]The option, representing the right to purchase 24,890 shares of InfuSystem Holdings, Inc. common stock, vests on May 12, 2027.
Signature
/s/ Kevin Whitman, Attorney-in-Fact for John J. Sviokla|2026-05-14

Documents

1 file
  • 4
    wk-form4_1778797926.xmlPrimary

    FORM 4